248 related articles for article (PubMed ID: 36440281)
1. Peak width of skeletonized mean diffusivity in cerebral amyloid angiopathy: Spatial signature, cognitive, and neuroimaging associations.
Zanon Zotin MC; Schoemaker D; Raposo N; Perosa V; Bretzner M; Sveikata L; Li Q; van Veluw SJ; Horn MJ; Etherton MR; Charidimou A; Gurol ME; Greenberg SM; Duering M; Dos Santos AC; Pontes-Neto OM; Viswanathan A
Front Neurosci; 2022; 16():1051038. PubMed ID: 36440281
[TBL] [Abstract][Full Text] [Related]
2. Peak width of skeletonized mean diffusivity and cognitive performance in cerebral amyloid angiopathy.
Horn MJ; Gokcal E; Becker JA; Das AS; Schwab K; Zanon Zotin MC; Goldstein JN; Rosand J; Viswanathan A; Polimeni JR; Duering M; Greenberg SM; Gurol ME
Front Neurosci; 2023; 17():1141007. PubMed ID: 37077322
[TBL] [Abstract][Full Text] [Related]
3. Cross-sectional and longitudinal differences in peak skeletonized white matter mean diffusivity in cerebral amyloid angiopathy.
McCreary CR; Beaudin AE; Subotic A; Zwiers AM; Alvarez A; Charlton A; Goodyear BG; Frayne R; Smith EE
Neuroimage Clin; 2020; 27():102280. PubMed ID: 32521475
[TBL] [Abstract][Full Text] [Related]
4. Peak Width of Skeletonized Mean Diffusivity as Neuroimaging Biomarker in Cerebral Amyloid Angiopathy.
Raposo N; Zanon Zotin MC; Schoemaker D; Xiong L; Fotiadis P; Charidimou A; Pasi M; Boulouis G; Schwab K; Schirmer MD; Etherton MR; Gurol ME; Greenberg SM; Duering M; Viswanathan A
AJNR Am J Neuroradiol; 2021 May; 42(5):875-881. PubMed ID: 33664113
[TBL] [Abstract][Full Text] [Related]
5. Mediators of cognitive impairment in cerebral amyloid angiopathy.
Durrani R; Wang M; Cox E; Irving E; Saad F; McCreary CR; Beaudin AE; Gee M; Nelles K; Sajobi TT; Ismail Z; Camicioli R; Smith EE
Int J Stroke; 2023 Jan; 18(1):78-84. PubMed ID: 35473418
[TBL] [Abstract][Full Text] [Related]
6. Microstructural white matter damage on MRI is associated with disease severity in Dutch-type cerebral amyloid angiopathy.
Rasing I; Vlegels N; Schipper MR; Voigt S; Koemans EA; Kaushik K; van Dort R; van Harten TW; De Luca A; van Etten ES; van Zwet EW; van Buchem MA; Middelkoop HA; Biessels GJ; Terwindt GM; van Osch MJ; van Walderveen MA; Wermer MJ
J Cereb Blood Flow Metab; 2024 Jun; ():271678X241261771. PubMed ID: 38886875
[TBL] [Abstract][Full Text] [Related]
7. Multi-Dimensional Diffusion Tensor Imaging Biomarkers for Cognitive Decline From the Preclinical Stage: A Study of Post-stroke Small Vessel Disease.
Du J; Zhu H; Yu L; Lu P; Qiu Y; Zhou Y; Cao W; Lu D; Zhao W; Yang J; Sun J; Xu Q
Front Neurol; 2021; 12():687959. PubMed ID: 34322083
[No Abstract] [Full Text] [Related]
8. Association Between Hippocampal Volumes and Cognition in Cerebral Amyloid Angiopathy.
Perosa V; Zanon Zotin MC; Schoemaker D; Sveikata L; Etherton MR; Charidimou A; Greenberg SM; Viswanathan A
Neurology; 2024 Jan; 102(2):e207854. PubMed ID: 38165326
[TBL] [Abstract][Full Text] [Related]
9. Age-Related Changes of Peak Width Skeletonized Mean Diffusivity (PSMD) Across the Adult Lifespan: A Multi-Cohort Study.
Beaudet G; Tsuchida A; Petit L; Tzourio C; Caspers S; Schreiber J; Pausova Z; Patel Y; Paus T; Schmidt R; Pirpamer L; Sachdev PS; Brodaty H; Kochan N; Trollor J; Wen W; Armstrong NJ; Deary IJ; Bastin ME; Wardlaw JM; Munõz Maniega S; Witte AV; Villringer A; Duering M; Debette S; Mazoyer B
Front Psychiatry; 2020; 11():342. PubMed ID: 32425831
[TBL] [Abstract][Full Text] [Related]
10. A Neuroimaging Marker Based on Diffusion Tensor Imaging and Cognitive Impairment Due to Cerebral White Matter Lesions.
Wei N; Deng Y; Yao L; Jia W; Wang J; Shi Q; Chen H; Pan Y; Yan H; Zhang Y; Wang Y
Front Neurol; 2019; 10():81. PubMed ID: 30814973
[No Abstract] [Full Text] [Related]
11. Association of Long-Term Blood Pressure Variability with Cerebral Amyloid Angiopathy-related Brain Injury and Cognitive Decline.
Sveikata L; Zotin MCZ; Schoemaker D; Ma Y; Perosa V; Chokesuwattanaskul A; Charidimou A; Duering M; Gurol EM; Assal F; Greenberg SM; Viswanathan A
medRxiv; 2024 Feb; ():. PubMed ID: 38464316
[TBL] [Abstract][Full Text] [Related]
12. Peak Width of Skeletonized Mean Diffusivity as a Marker of Diffuse Cerebrovascular Damage.
Low A; Mak E; Stefaniak JD; Malpetti M; Nicastro N; Savulich G; Chouliaras L; Markus HS; Rowe JB; O'Brien JT
Front Neurosci; 2020; 14():238. PubMed ID: 32265640
[TBL] [Abstract][Full Text] [Related]
13. Associations of MRI-Derived Glymphatic System Impairment With Global White Matter Damage and Cognitive Impairment in Mild Traumatic Brain Injury: A DTI-ALPS Study.
Yang DX; Sun Z; Yu MM; Zou QQ; Li PY; Zhang JK; Wu X; Li YH; Wang ML
J Magn Reson Imaging; 2024 Feb; 59(2):639-647. PubMed ID: 37276070
[TBL] [Abstract][Full Text] [Related]
14. Glymphatic dysfunction correlates with severity of small vessel disease and cognitive impairment in cerebral amyloid angiopathy.
Xu J; Su Y; Fu J; Wang X; Nguchu BA; Qiu B; Dong Q; Cheng X
Eur J Neurol; 2022 Oct; 29(10):2895-2904. PubMed ID: 35712978
[TBL] [Abstract][Full Text] [Related]
15. Microstructural white matter integrity in relation to vascular reactivity in Dutch-type hereditary cerebral amyloid angiopathy.
Schipper MR; Vlegels N; van Harten TW; Rasing I; Koemans EA; Voigt S; Luca A; Kaushik K; van Etten ES; van Zwet EW; Terwindt GM; Biessels GJ; van Osch MJ; van Walderveen MA; Wermer MJ
J Cereb Blood Flow Metab; 2023 Dec; 43(12):2144-2155. PubMed ID: 37708241
[TBL] [Abstract][Full Text] [Related]
16. Diffusion tensor tractography of the fornix in cerebral amyloid angiopathy, mild cognitive impairment and Alzheimer's disease.
Shaikh I; Beaulieu C; Gee M; McCreary CR; Beaudin AE; Valdés-Cabrera D; Smith EE; Camicioli R
Neuroimage Clin; 2022; 34():103002. PubMed ID: 35413649
[TBL] [Abstract][Full Text] [Related]
17. Association between white matter alterations and domain-specific cognitive impairment in cerebral small vessel disease: A meta-analysis of diffusion tensor imaging.
Xie Y; Xie L; Kang F; Jiang J; Yao T; Mao G; Fang R; Fan J; Wu D
Front Aging Neurosci; 2022; 14():1019088. PubMed ID: 36483114
[TBL] [Abstract][Full Text] [Related]
18. Relationship of Perivascular Space Markers With Incident Dementia in Cerebral Small Vessel Disease.
Hong H; Tozer DJ; Markus HS
Stroke; 2024 Apr; 55(4):1032-1040. PubMed ID: 38465597
[TBL] [Abstract][Full Text] [Related]
19. Late-life depression accentuates cognitive weaknesses in older adults with small vessel disease.
Oberlin LE; Respino M; Victoria L; Abreu L; Hoptman MJ; Alexopoulos GS; Gunning FM
Neuropsychopharmacology; 2022 Jan; 47(2):580-587. PubMed ID: 33564103
[TBL] [Abstract][Full Text] [Related]
20. Clinical significance of amyloid β positivity in patients with probable cerebral amyloid angiopathy markers.
Jang H; Jang YK; Kim HJ; Werring DJ; Lee JS; Choe YS; Park S; Lee J; Kim KW; Kim Y; Cho SH; Kim SE; Kim SJ; Charidimou A; Na DL; Seo SW
Eur J Nucl Med Mol Imaging; 2019 Jun; 46(6):1287-1298. PubMed ID: 30937462
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
